相关实验视频

Updated: Jun 3, 2025

A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status

A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status

Published on: October 20, 2016

一项全面的蛋白质组学分析揭示了内动脉瘤中的新型炎症生物标志物

Siqi Chen¹, Ziliang Hu¹, Mingyue Zhao¹

¹Ningbo Key Laboratory of Nervous System and Brain Function, Department of Neurosurgery, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang 315010, China; Key Laboratory of Precision Medicine for Atherosclerotic Diseases of Zhejiang Province, Ningbo, Zhejiang 315010, China.

Journal of proteomics

|January 6, 2025

概括

研究人员确定了关键的炎症蛋白质生物标志物,包括IL6,PTX3,LPL和OLR1,用于早期检测内动脉瘤 (IA). 首次报告IA患者的OLR1升高,为诊断和研究提供了新的途径.

科学领域:

血管生物学血管生物学
免疫学免疫学免疫学
生物化学生物化学

背景情况:

炎症在内动脉瘤 (IA) 发育中起作用,但特定的炎症因素尚未完全理解.
识别这些因素对于早期诊断和了解IA病原体至关重要.

研究的目的:

识别和验证与血管炎症相关的蛋白质生物标志物,用于早期检测内动脉瘤 (IA).
研究包括OLR1在内的特定蛋白质在IA病原发生中的作用.

主要方法:

使用奥林克CVD II血管炎症小组对两个队列进行蛋白质组分析.
使用ELISA和RT-qPCR验证差异表达蛋白质.
对综合生物标志物小组进行诊断潜力的评估.

主要成果:

在IA患者和对照人群中,与血管炎症相关的11个标志物显著不同.
证实IL6,PTX3,LPL和OLR1具有差异的代表性.
这四种标记物的组合显示出早期IA检测的高诊断潜力.
在IA患者中首次报告显著升高的OLR1血水平.

结论:

IL6,PTX3,LPL和OLR1是早期诊断内动脉瘤 (IA) 的有希望的生物标志物.
在IA患者中OLR1升高的新发现,需要进一步调查其在IA病变发生中的作用.
这些生物标志物可以帮助开发有针对性的疗法和改善IA管理.

关键词:

生物标志物生物标志物炎症炎症是一种炎症.内动脉瘤是一个内动脉瘤.一个OLR1一个OLR1 奥林克的蛋白质组学

更多相关视频

Systems Analysis of the Neuroinflammatory and Hemodynamic Response to Traumatic Brain Injury

Systems Analysis of the Neuroinflammatory and Hemodynamic Response to Traumatic Brain Injury

Published on: May 27, 2022

Sample Preparation for Endopeptidomic Analysis in Human Cerebrospinal Fluid

Sample Preparation for Endopeptidomic Analysis in Human Cerebrospinal Fluid

Published on: December 4, 2017

相关概念视频

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...